Matches in Wikidata for { <http://www.wikidata.org/entity/Q37452849> ?p ?o ?g. }
- Q37452849 description "article científic" @default.
- Q37452849 description "article scientifique" @default.
- Q37452849 description "articolo scientifico" @default.
- Q37452849 description "artigo científico" @default.
- Q37452849 description "artículu científicu espublizáu en 2009" @default.
- Q37452849 description "bilimsel makale" @default.
- Q37452849 description "scientific article published on 21 April 2009" @default.
- Q37452849 description "vedecký článok" @default.
- Q37452849 description "vetenskaplig artikel" @default.
- Q37452849 description "videnskabelig artikel" @default.
- Q37452849 description "vědecký článek" @default.
- Q37452849 description "wetenschappelijk artikel" @default.
- Q37452849 description "wissenschaftlicher Artikel" @default.
- Q37452849 description "наукова стаття, опублікована у квітні 2009" @default.
- Q37452849 description "научни чланак" @default.
- Q37452849 description "مقالة علمية نشرت في 21 أبريل 2009" @default.
- Q37452849 name "The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents" @default.
- Q37452849 name "The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents" @default.
- Q37452849 name "The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents" @default.
- Q37452849 type Item @default.
- Q37452849 label "The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents" @default.
- Q37452849 label "The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents" @default.
- Q37452849 label "The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents" @default.
- Q37452849 prefLabel "The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents" @default.
- Q37452849 prefLabel "The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents" @default.
- Q37452849 prefLabel "The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents" @default.
- Q37452849 P1433 Q37452849-6B3EE7EF-F7BB-4539-95FA-1E33666ECAC3 @default.
- Q37452849 P1476 Q37452849-AE7C6451-8CF7-4B08-903D-70E1E910201B @default.
- Q37452849 P2093 Q37452849-184E5567-4954-4F7B-8017-5928BC1DCE33 @default.
- Q37452849 P2093 Q37452849-A19BBA1C-EDEC-4463-853E-DABDA1824E69 @default.
- Q37452849 P2093 Q37452849-CD2F4D46-FF49-496C-ABD1-4A259F92B2EC @default.
- Q37452849 P2093 Q37452849-CD863DC8-2EC9-4EFB-ADDF-29A48DD31193 @default.
- Q37452849 P2093 Q37452849-F29303C2-B5E5-4585-9A44-08D4D1E56DDE @default.
- Q37452849 P2860 Q37452849-01DA89D2-2B77-41AD-AB44-B0489501FE4A @default.
- Q37452849 P2860 Q37452849-080989FC-6643-410A-BA07-309E78BF8C5D @default.
- Q37452849 P2860 Q37452849-0A22D3DA-30D1-4B3C-B4E6-70F8054D81DE @default.
- Q37452849 P2860 Q37452849-0DDAFA83-54BE-4F2B-986F-D54F9E485F34 @default.
- Q37452849 P2860 Q37452849-11258A10-CC0A-49D5-A6BD-A3CD7D919E86 @default.
- Q37452849 P2860 Q37452849-12224D3A-1D26-442A-AE5D-5F8D801327C1 @default.
- Q37452849 P2860 Q37452849-15300E2B-1671-4AE7-973C-8D44A378EAC0 @default.
- Q37452849 P2860 Q37452849-2D1223DB-8BF5-4A1D-B7F8-CA0B8764016A @default.
- Q37452849 P2860 Q37452849-39FDC961-A3D4-42DB-8B8B-0671EE0F54D2 @default.
- Q37452849 P2860 Q37452849-5AA2AAD4-DB0D-49CC-97EB-11168959A43E @default.
- Q37452849 P2860 Q37452849-5EC7CC93-11AC-4ECA-B458-A879CF52B56D @default.
- Q37452849 P2860 Q37452849-5F99CC32-0B8F-45D3-9CE4-5EE9FA017040 @default.
- Q37452849 P2860 Q37452849-5FD135E8-A1C0-4D61-AC1C-E78C370AE4A9 @default.
- Q37452849 P2860 Q37452849-61C8846F-D51A-4E96-90F9-6614B26CF1A4 @default.
- Q37452849 P2860 Q37452849-6425093A-0B5C-4952-8452-9D73997D56BC @default.
- Q37452849 P2860 Q37452849-75DCFF31-511B-4C80-BA38-0B8708E689AF @default.
- Q37452849 P2860 Q37452849-7BBA41EC-B93F-4F6C-BAEC-DBBA24545772 @default.
- Q37452849 P2860 Q37452849-8EA30758-E4F6-4CA1-9472-F71DDAC64C24 @default.
- Q37452849 P2860 Q37452849-9C3ADC86-D961-47C6-8300-50ED29318509 @default.
- Q37452849 P2860 Q37452849-A159613E-431F-4C3C-AA84-FA7A685A7BE5 @default.
- Q37452849 P2860 Q37452849-A1933173-9DEB-48DD-AA8F-BB971AAB1F45 @default.
- Q37452849 P2860 Q37452849-ADC9389A-0907-4431-934F-C75C1CE8F853 @default.
- Q37452849 P2860 Q37452849-AF8F6AA3-D934-4C45-ACE5-7134848F43F1 @default.
- Q37452849 P2860 Q37452849-B0577F36-6A22-44E5-A509-5E7B5EAC7011 @default.
- Q37452849 P2860 Q37452849-B7C9B956-51C4-4BF3-ADEE-470E1262601A @default.
- Q37452849 P2860 Q37452849-BAFEC604-F598-4B88-AB65-BE0A11EC6A13 @default.
- Q37452849 P2860 Q37452849-BE9AFA2B-82EF-4700-8581-64133AC41E04 @default.
- Q37452849 P2860 Q37452849-C33238AC-8A08-4D8F-B5CD-A6AB28389D08 @default.
- Q37452849 P2860 Q37452849-D2BBD5FA-01E9-4CDE-BFA1-5FA522EFF9D8 @default.
- Q37452849 P2860 Q37452849-D829A115-F468-439D-BB9C-14475B01CABE @default.
- Q37452849 P2860 Q37452849-E319723D-995D-4F8F-B65F-173AD9BD05E4 @default.
- Q37452849 P2860 Q37452849-E83C96DD-11D1-442D-9D56-D4DB03371140 @default.
- Q37452849 P2860 Q37452849-ED3EDDC0-5327-4CD3-AA48-314EAF62B9FB @default.
- Q37452849 P2860 Q37452849-F0D09BD5-5C57-4D09-B22E-90DC6899E311 @default.
- Q37452849 P2860 Q37452849-FCD4CB5B-42DD-49E4-9523-74B74C651BD7 @default.
- Q37452849 P2888 Q37452849-92E81762-4CE1-4100-8B7A-4D4D7AD38C38 @default.
- Q37452849 P304 Q37452849-7E41F1EA-B85B-4428-BAD4-6BBF8C78D3C1 @default.
- Q37452849 P31 Q37452849-D2EE19F9-A2CF-4FF6-896C-FFB7373467A5 @default.
- Q37452849 P31 Q37452849-b25e5a10-4b35-473e-9816-1b75ca60bb7d @default.
- Q37452849 P356 Q37452849-36BFC3BA-F76C-49EA-AFA9-534480689BC5 @default.
- Q37452849 P433 Q37452849-6196F8E2-E598-4D7E-97FF-E5E37C344F49 @default.
- Q37452849 P478 Q37452849-2FE623D4-B532-447F-8D19-4386A378A246 @default.
- Q37452849 P50 Q37452849-E6A7D3BD-D03E-4A14-9C77-A5837B6DF1B0 @default.
- Q37452849 P577 Q37452849-6D0224D5-99CF-4E12-B05F-9D38630490FD @default.
- Q37452849 P698 Q37452849-ACB06F6D-3077-4207-89F1-14B38BF83A2D @default.
- Q37452849 P356 S11523-009-0107-Z @default.
- Q37452849 P698 19381454 @default.
- Q37452849 P1433 Q25378200 @default.
- Q37452849 P1476 "The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents" @default.
- Q37452849 P2093 "Alain Mita" @default.
- Q37452849 P2093 "Devalingam Mahalingam" @default.
- Q37452849 P2093 "Kamalesh Sankhala" @default.
- Q37452849 P2093 "Kevin Kelly" @default.
- Q37452849 P2093 "Monica Mita" @default.
- Q37452849 P2860 Q28374428 @default.
- Q37452849 P2860 Q29615120 @default.
- Q37452849 P2860 Q29618031 @default.
- Q37452849 P2860 Q29618608 @default.
- Q37452849 P2860 Q32048820 @default.
- Q37452849 P2860 Q33332340 @default.
- Q37452849 P2860 Q33332820 @default.
- Q37452849 P2860 Q33339059 @default.
- Q37452849 P2860 Q33360724 @default.
- Q37452849 P2860 Q33366766 @default.
- Q37452849 P2860 Q33366976 @default.
- Q37452849 P2860 Q33379469 @default.
- Q37452849 P2860 Q34010378 @default.